DNA helix

Own the capability – eliminate uncertainty

Retain control of your projects with in-house DNA Synthesis

Produce high-quality, ssDNA oligos, in-house, overnight, with complete confidence and autonomy.

DISCOVER SYNTAX

Designed for labs who require reliability, speed and ease

DNASCRIPT SYNTAX instrument
  • Reliability icon

    Reliability

    Quality and reliability you can trust — every run, every oligo.

  • Speed icon

    Speed

    Overnight oligos — ready-to-use when you are ready-to-go.

  • Ease of use icon

    Ease of Use

    From workflow to output, each element designed for ease.

SYNTAX Testimonial Icon
“A major bottle neck in executing synthetic biology workflows is the time delay in obtaining synthetic DNA from commercial suppliers. The exciting new SYNTAX platform allows us to synthesize DNA on demand, which not only speeds up our internal design-build-test-learn cycle but allows us to control our own workflow and maximize access to our synthetic biology design space.”
Paul Freemont PhD,
Head of Structural and Synthetic Biology and the London Biofoundry at Imperial College London

Built for

  • dsDNA providers
  • CROs
  • Core facilities
  • Biotech companies
  • Pharma companies
  • Governmental agencies
Scientist working in lab Scientist head overlay

News & Events

Coalition for Epidemic Preparedness Innovations
PRESS RELEASE
Pushing mRNA vaccine development timelines to new speeds
6 February 2025; OSLO; PARIS: Scientists in Paris are set to advance new technology that could streamline the production of … Learn More  
Representatives from EVA Pharma, DNA Script, Quantoom Biosciences signing MoU
MEDIA COVERAGE
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, …
CAIRO, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a … Learn More  

READ THE LATEST NEWS